Breaks Categories: News

TuesdayJun 19, 2018 10:39 am

PsychedelicNewsBreaks – Marijuana Company of America Inc.’s (MCOA) hempSMART Brand Launches New CBD-Infused Moisturizer

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) this morning announced that the company’s hempSMART™ brand has launched its groundbreaking new cosmetic product, hempSMART™ Face. The newly developed topical product is formulated with 150mg of full spectrum, non-psychoactive Cannabidiol (“CBD”) oil derived from the industrial hemp plant. hempSMART™ Face is a facial moisturizer designed to refresh, replenish, and restore skin cells using a combination of CBD oil and a unique blend of ayurvedic herbs and botanicals. “Our team is excited to announce the expansion of the hempSMART™ brand into the world of cosmetic products. HempSMART™ will continue…

Continue Reading

TuesdayMay 22, 2018 10:40 am

PsychedelicNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) Enters Exclusive License Agreement with CBx Enterprises

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) today announced that it has entered into an exclusive license agreement with CBx Enterprises LLC to license Evolab and CBx Sciences brands and proprietary technologies and formulations in Canada and other areas outside of the USA. TGOD’s product and technology portfolio will be directly increased by the licensing arrangement. “This licensing partnership for industry leading technologies and formulations will further allow TGOD to execute on its plans of offering novel and safer delivery methods of both non-psychoactive and psychoactive cannabinoids to patients and consumers around the globe,”…

Continue Reading

ThursdayMar 22, 2018 10:41 am

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives Notice of Allowance from United States Patent and Trademark Office

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has received a new Notice of Allowance from the United States Patent and Trademark Office ("USPTO") covering "composition of matter" claims which protect the specific combination of substances that enables improved taste and the bioabsorption properties of its DehydraTECH™ technology for the delivery of cannabinoids. The newly-granted patent is a substantial addition to Lexaria's previously granted manufacturing method of use patent. In accordance with USPTO practice, there is no opposition period between allowance and issuance. The patent application number is 15/225,802 titled, "Food and…

Continue Reading

MondayFeb 26, 2018 9:29 am

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Global Licensing Agreement with Neutrisci International Inc. (TSX-V: NU) (OTCQB: NRXCF)

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning said it has entered an agreement with NeutriSci International Inc. (TSX-V: NU) (OTCQB: NRXCF) resulting in NeutriSci now having 100% ownership of Ambarii Trade Corporation. Lexaria has also granted to NeutriSci an Intellectual Property License and Supply Agreement for the manufacturing and sale of CBD based products. Per the License Agreement, NeutriSci will remain focused on the development and sales of its existing and pipeline products that include Lexaria's technology for enhancing palatability and bioavailability of beneficial non-psychoactive cannabinoids. Lexaria will receive continuing royalty revenues from the sales generated by these products.…

Continue Reading

TuesdayFeb 20, 2018 9:56 am

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Expands hempSMART™ Line with Full Spectrum Pet Drops

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) this morning announced the release of hempSMART™ Full Spectrum Pet Drops, a natural product line formulated with 250mg of full spectrum non-psychoactive cannabidiol (“CBD”) derived from industrial hemp. Per the update, in addition to naturally-occurring CBD, the specially-formulated product contains full spectrum hemp extract, fractionated coconut oil and a rich bacon flavor. “Our new hempSMART product is a natural option for pet owners who care about supporting their animals’ healthy energy levels as well as optimizing their health,” Donald Steinberg, CEO of MCOA, stated in the news release. “Our…

Continue Reading

ThursdayJan 11, 2018 11:31 am

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Subsidiary Announces Launch of hempSMART™ Pain Cream

Marijuana Company of America, Inc. (OTC: MCOA), through wholly owned subsidiary hempSMART™, Inc., this morning announced the launch of hempSMART Pain Cream. Per the update, each bottle of hempSMART Pain Cream is formulated with 300mg of full spectrum non-psychoactive cannabidiol derived from industrial hemp. Utilizing a proprietary blend of Ayurvedic herbs, menthol, cayenne pepper extract, rosemary oil, aloe gel, white willow bark, arnica, wintergreen extract and tea tree oil, hempSMART Pain Cream provides what the company calls an immediate cooling and soothing sensation. “We are excited to announce the expansion of our hempSMART personal care product line to include pain…

Continue Reading

ThursdayDec 14, 2017 10:36 am

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Adds New Pain Product to Lineup

Marijuana Company of America (OTC: MCOA) announced today the launch of its new personal care product hempSMART Pain for the temporary treatment of minor pain associated with physical activity using non-psychoactive cannabidiol. "HempSMART demonstrated its commitment to formulating a safe and synergistic natural personal care product. The hempSMART Pain formula harnesses the natural power of premium CBD, CBG and active terpenes derived from industrial hemp, combined with complimentary botanicals,” Paula Vetter, a member of hempSMART's product development team, stated in a news release about the product. To view the full press release, visit http://cnw.fm/G61Yr. About Marijuana Company of America, Inc.…

Continue Reading

WednesdayOct 18, 2017 11:29 am

PsychedelicNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters Collaboration Agreement with Phasex Corporation

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, this morning announced a collaboration with Phasex Corporation, one of the world’s most experienced supercritical fluid (“SCF”)-based toll processors. The goal of the collaboration is to combine PBI’s recently patented Ultra Shear Technology with Phasex’s SCF-based processing methods to enable the development of stable, water-soluble nanoemulsions of nutraceuticals, including CBD-enriched plant oil. “Rapidly expanding markets for non-psychoactive extracts of cannabis plant material, for instance, is an example of a potentially high demand application for our combined, synergistic technologies,” Richard…

Continue Reading

FridayOct 13, 2017 11:34 am

PsychedelicNewsBreaks – International Endeavors Corp. (IDVV) Enters MOU with Kubby Cryogenics, Inc. to Expand Medical Cannabis Line

International Endeavors (OTC: IDVV) this morning said that it has signed a memorandum of understanding (MOU) with Kubby Cryogenics, Inc. Per the agreement, Kubby Cryogenics will seek to patent medical grade cannabis strains that are genetically profiled to treat specific diseases. The agreement also states that Steve Kubby will immediately become CEO of International Endeavors. Kubby Cryogenics has assembled a team of top scientists and geneticists to continue developing the company’s proprietary cryogenics products. "We will create a dispensary system for legal medical cannabis states standardizing the patient centered, consultation approach while presenting an enticing line of Adult Use products…

Continue Reading

TuesdayOct 03, 2017 9:28 am

PsychedelicNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Announces Filing of Provisional Patent for Cannabinoid-Based Pain Treatment

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the filing of a provisional patent application in the United States for INM-405 and other unique compositions as cannabinoid-based topical therapies for the treatment of pain, marking an important step toward protection of the company’s intellectual and commercial property. “There remains a significant need in the field of analgesia for a product that can treat pain via a topical route of administration, which would reduce systemic exposure and any associated side effects,” Dr. Sazzad Hossain, chief scientific officer of InMed and a co-inventor on the newly-filed…

Continue Reading